Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
08/13/2017 08/14/2017 08/15/2017 08/16/2017 08/17/2017 Date
6322(c) 6200(c) 6267(c) 6435(c) 6362(c) Last
649 596 1 456 242 1 059 479 2 230 302 577 178 Volume
+0.70% -1.93% +1.08% +2.68% -1.13% Change
More quotes
Financials ($)
Sales 2017 23 033 M
EBIT 2017 6 610 M
Net income 2017 -
Debt 2017 31 255 M
Yield 2017 -
Sales 2018 22 288 M
EBIT 2018 6 062 M
Net income 2018 -
Debt 2018 26 955 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 2,13x
EV / Sales2018 2,01x
Capitalization 17 816 M
More Financials
Company
Teva Pharmaceutical Industries Ltd. engages in the provision of pharmaceutical services.It operates through the following two segments: Generic and Specialty Medicine.The Generic segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including... 
More about the company
Latest news on TEVA PHARMACEUTICAL INDUST
08/18DJCorrection to Biogen Treads Tricky Path Between Politicians, Investors Articl..
08/18 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Axiron® i..
08/17 Drugmaker Hikma trims sales forecasts, shares fall
08/17 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Today's Research Reports on Stocks to Wat..
08/15 TEVA PHARMACEUTICAL INDUSTRIES : Check Point overtakes Teva to become Israel's m..
08/11 TEVA PHARMACEUTICAL INDUSTRIES : parties as share price plunges to new low
08/10 TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of Generic Epiduo® in the Unit..
08/10 TEVA PHARMACEUTICAL INDUSTRIES : Ayalim Mutual Funds buying Teva shares
08/10 Check Point set to surpass Teva as Israel's biggest company
08/10 CELLTRION : and Teva Announce U.S. FDA Acceptance of Biologics License Applicati..
More news
Sector news : Pharmaceuticals - NEC
08/18DJCorrection to Biogen Treads Tricky Path Between Politicians, Investors Articl..
08/18DJMERCK AND : Scientists, Out $12 Million, Sue Delaware Over Seizure of Their Stoc..
08/18DJASTRAZENECA : FDA Approves AstraZeneca's Ovarian Cancer Treatment Lynparza Table..
08/17 FDA expands use of AstraZeneca/Merck ovarian cancer drug
08/17 Drugmaker Hikma trims sales forecasts, shares fall
More sector news : Pharmaceuticals - NEC
Latest Tweets
08/18Teva Pharmaceutical Industries Limited 2017 Q2 - Results - Earnings Call Slid.. 
08/16Teva Pharmaceutical Industries Limited downgraded by BidaskClub to strong sel.. 
08/16Fernwood Investment Management LLC Increases Position in Teva Pharmaceutical .. 
08/16Teva Pharmaceutical Industries Limited $TEVA Cut to “Neutral” at Citigroup In.. 
08/16Teva Pharmaceutical Industries Limited downgraded by Citigroup Inc. to neutra.. 
More tweets
Qtime:30
News from SeekingAlpha
08/18 Teva Pharmaceutical Industries Limited 2017 Q2 - Results - Earnings Call Slid..
08/18 Teva launches generic Axiron in U.S.
08/18 SNIPPET ROUNDUP : Transparency For Straumann But A Black Box For Pfizer
08/18 TGIF - Market Ends Week On A Rough Note
08/18 Tracking John Paulson's Paulson & Company Portfolio - Q2 2017 Update
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 31,3 $
Spread / Average Target 78%
EPS Revisions
Managers
NameTitle
Yitzhak Peterburg President & Chief Executive Officer
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael R. Hayden President-Global Research & Development
Roger Abravanel Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-54.03%17 816
JOHNSON & JOHNSON15.12%357 079
ROCHE HOLDING LTD.4.99%218 752
NOVARTIS8.84%218 545
PFIZER0.59%196 221
MERCK AND COMPANY4.45%168 660